Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
115.00    3.50 (3.14%)
Bid:
112.00
Ask:
118.00
Spread: 6.00 (5.357%)
Market Cap: £69.19m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Statement

5 Oct 2017 07:00

RNS Number : 7371S
Intercede Group PLC
05 October 2017
 

 

5 October 2017

INTERCEDE GROUP plc

("Intercede", or the "Group")

Trading Update

Intercede, the leading specialist in digital identity, credential management and secure mobility, today announces a trading update for the first six months of its current financial year ending 31 March 2018.

First half revenues increased by approximately 30% compared to the previous period to more than £3.6m (H1 2016: £2.8m) primarily due to new customer wins; the most notable including MyID license sales to the largest US military shipbuilding company, a major US Aerospace & Defence contractor and one of the world's largest diversified natural resource companies. 

As at 30 September 2017, cash balances totalled £4.8m compared to £1.4m as at 30 September 2016. Intercede raised £4.6m (net) from the issue of Convertible Loan Notes ("CLN") and new equity in January 2017 with a further £0.5m from the same CLN instruments in August 2017.

During the period under review, Intercede has continued to develop the applications for its market leading identity software. This includes the launch of the MyID service for employees. This is a cloud-based service that allows enterprises of all sizes to eliminate the use of user passwords through the issuance of strong identity credentials to staff members. This service uses Government-grade cyber security and avoids customers having to incur the costs and complexity of on-site software installation and maintenance.

Several significant appointments have also been made to strengthen the Group's Sales & Marketing. Chuck Pol (former Chairperson Vodafone Americas) and Helen Adams (former VP Sales Europe & Asia/Pacific for ARM Holdings plc) were both appointed in June 2017 with further recruitment subsequently taking place to expand and refresh the Sales team. As a commitment to achieving consequential high sales growth, Helen Adams has this week agreed to a share option plan incorporating performance targets based upon the achievement of 50% growth on FY2017 revenues in FY2018, a doubling of FY2017 revenues in FY2019 and a tripling of FY17 revenues in FY2020.

Commenting on the trading update, Richard Parris, Chairman & CEO of Intercede said;

"The last six months have been a positive period for Intercede. Progress has been made in our existing core market within government agencies and large enterprises. Enabled by our enlarged sales team, we have strengthened our European sales pipeline to diversify away from our heavy dependency on the US government centric market. We have also made significant future-facing business development advances with multiple major IT and cloud service providers. These partnerships are expected to be pivotal to Intercede's channel based go-to-market strategy and are evidence of our ongoing leadership in powering digital trust solutions.

Safe in the knowledge that we have created a significant engine for growth, we are shortly to relaunch our MyID product proposition as a seamless suite of software and Cloud based services to address newly emerging regulated markets in financial services, open banking and general data protection. In doing so, we can refocus and simplify messaging around real-life use cases and the problems we solve for each of our target verticals. This gives the Board confidence that we will experience a strong second half to the financial year, notwithstanding likely budget difficulties in our traditionally large US government customer base."

 

ENQUIRIES

Intercede Group plc

Tel: +44 (0) 1455 558 111

Richard Parris

Chairman & Chief Executive

Andrew Walker

Finance Director

finnCap

Tel: +44 (0) 20 7220 0500

Stuart Andrews

Corporate Finance

Simon Hicks

Corporate Finance

Capital Access Group

Tel: +44 (0) 20 3763 3400

Scott Fulton

Media

Ed Welsby

Investors

 

About Intercede

Intercede is a software and service company specializing in identity, credential management and secure mobility. Its solutions create a foundation of trust between connected people, devices and apps and combine expertise with innovation to provide world-class cybersecurity. Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years. Intercede's product portfolio includes MyID, an identity and credential management system that assigns trusted digital identities to employees citizens and machines. In 2015, Intercede launched MyTAM, enabling trusted applications to be loaded into a mobile device's Trusted Execution Environment (TEE), providing hardware-level security for Android apps. In 2016, Intercede launched RapID, a secure, easy to implement authentication service for mobile apps and cloud services to completely eliminate the need for passwords.

For more information visit: www.intercede.com

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLBDGBGGBGRS
Date   Source Headline
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity
10th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSBoard Changes
8th Jun 20227:00 amRNSFinal Results
25th May 202210:15 amRNSInvestor Presentation
12th Apr 20227:00 amRNSAppointment of CFO
6th Apr 20227:00 amRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSTrading Update & Contract Win
30th Mar 202210:01 amRNSReceipt of $3.4m Order
2nd Feb 20227:00 amRNSContract Win
8th Dec 20213:55 pmRNSDirector/PDMR Shareholding and Issue of Equity
23rd Nov 20217:00 amRNSHalf-year Report
19th Nov 20217:00 amRNSHolding(s) in Company-Amendment
17th Nov 20217:00 amRNSInvestor Presentation
16th Nov 20217:00 amRNSHolding(s) in Company
15th Nov 20213:45 pmRNSTotal Voting Rights
11th Nov 20214:12 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSTrading Update
15th Sep 20212:09 pmRNSResult of AGM
15th Sep 20217:00 amRNSMultiple Customers choose to Upgrade MyID

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.